Maze Therapeutics, Inc. Common Stock (MAZE)
Healthcare
Biotechnology
—
26.90 $
-2.6%
vs. previous close
Closing price · As of: 31. Jul 2026
Maze Therapeutics, Inc. Common Stock (MAZE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -112 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -99 | -87 | 76 | -112 | |
| 3.8 | 4.1 | 3.3 | 2.4 | |
| 6.7 | 8.7 | 9.6 | 16 | |
| -3.2 | -6.3 | -1.5 | -2.3 | |
| 2.0 | 0.4 | 1.1 | 0.8 | |
| -3.2 | -0.4 | -1.1 | -171 | |
| – | – | – | 1.3 | |
| 0.0 | 16 | 24 | 0.0 | |
| 1.7 | 16 | 93 | 275 | |
| -101 | -71 | 168 | -7.6 | |
| -101 | -87 | 75 | -113 |
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.